Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of carbon and nitrogen source variation on B-vitamin accumulation in <i>Yarrowia lipolytica</i>: Toward microbial fortification of food ingredients.

Biochemistry and biophysics reports·2026
Same author

Engineering <i>Clostridium Tyrobutyricum</i> for High Butanol Production through Induction Expression of Exogenous NADPH-Dependent HBD.

ACS synthetic biology·2026
Same author

Recent advances in engineering microbial lipases for industrial applications.

Biotechnology advances·2025
Same author

In-Silico Analysis and Engineering of an Aldehyde/Alcohol Dehydrogenase for Alternative Cofactor Utilization and Selective Butanol Production.

ACS synthetic biology·2025
Same author

Metabolic Engineering of <i>Clostridium tyrobutyricum</i> for High-Yield <i>n</i>-Butanol Production by Increasing Intracellular Reducing Equivalent with NADPH-Dependent 3-Hydroxybutyryl-CoA Dehydrogenase.

ACS synthetic biology·2025
Same author

Development of 3D Cell-Based Fluorescent Reporter Assay for Screening of Drugs Downregulating Telomerase Reverse Transcriptase.

Bioengineering (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jul 8, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

Microbioreactors for high-throughput cytotoxicity assays.

Shang-Tian Yang1, Xudong Zhang, Yuan Wen

  • 1The Ohio State University, Department of Chemical and Biomolecular Engineering, 140 West 19th Avenue, Columbus, OH 43210, USA. yang.15@osu.edu

Current Opinion in Drug Discovery & Development
|January 5, 2008
PubMed
Summary

Three-dimensional (3D) cell cultures in microfluidic bioreactors offer advanced in vitro models for drug discovery. These systems overcome limitations of 2D cultures, enabling better prediction of drug absorption, distribution, metabolism, elimination, and toxicity (ADMET).

More Related Videos

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

Related Experiment Videos

Last Updated: Jul 8, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Published on: February 2, 2013

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Cell Biology and Tissue Engineering
  • Biomedical Engineering

Background:

  • Cell culture is crucial for drug discovery, manufacturing, and regenerative medicine.
  • Conventional 2D cell cultures lack the 3D scaffold needed to mimic in vivo conditions, limiting their accuracy in cytotoxicity assays.
  • Three-dimensional (3D) cell cultures are essential for developing representative in vitro tissue models.

Purpose of the Study:

  • To highlight the advantages of 3D cell cultures in microfluidic bioreactors for drug discovery and bioprocess development.
  • To discuss the limitations of 2D cell cultures and the necessity of 3D scaffolds.
  • To explore the role of microfluidic bioreactors in advancing cell-based assays.

Main Methods:

  • Utilizing microfluidic bioreactors with miniaturized culturing vessels for high controllability and on-line monitoring.
  • Developing novel cell lines and reporter gene techniques.
  • Employing microfabrication, microfluidics, and advanced sensor technologies (optical, electrochemical) for non-invasive, real-time monitoring.
  • Implementing continuous perfusion for long-term culturing and studying systemic toxicity on biochips.

Main Results:

  • Microfluidic bioreactors enable dynamic monitoring of cell viability and activity using reporter genes and label-free techniques.
  • Continuous perfusion allows for the study of chronic toxicity effects.
  • Biochips facilitate the investigation of systemic toxicity and cell-cell interactions.
  • High-density microfluidic arrays pave the way for high-throughput and high-content screening.

Conclusions:

  • Microfluidic bioreactors with 3D cell cultures provide more representative in vitro models for drug discovery.
  • Advancements in microfluidics and sensor technology enhance the capabilities of cell-based assays.
  • These systems are critical for improving drug target validation, ADMET studies, and bioprocess development.